This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Jan 23;51(4):941-4.

doi: 10.1002/anie.201106527. Epub 2011 Dec 15.

A traceless vascular-targeting antibody-drug conjugate for cancer therapy

Gonçalo J L Bernardes¹, Giulio Casi, Sabrina Trüssel, Isabelle Hartmann, Kathrin Schwager, Jörg Scheuermann, Dario Neri

Affiliations

PMID: 22173886
DOI: 10.1002/anie.201106527

A traceless vascular-targeting antibody-drug conjugate for cancer therapy

Gonçalo J L Bernardes et al. Angew Chem Int Ed Engl. 2012.

. 2012 Jan 23;51(4):941-4.

doi: 10.1002/anie.201106527. Epub 2011 Dec 15.

Authors

Gonçalo J L Bernardes¹, Giulio Casi, Sabrina Trüssel, Isabelle Hartmann, Kathrin Schwager, Jörg Scheuermann, Dario Neri

Affiliation

¹ Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Wolfgang-Pauli Str. 10, 8093 Zürich, Switzerland.

PMID: 22173886
DOI: 10.1002/anie.201106527

No abstract available

PubMed Disclaimer

Similar articles

Antibody-drug conjugates for the treatment of cancer.
Flygare JA, Pillow TH, Aristoff P. Flygare JA, et al. Chem Biol Drug Des. 2013 Jan;81(1):113-21. doi: 10.1111/cbdd.12085. Chem Biol Drug Des. 2013. PMID: 23253133 Review.
An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance.
Hamann PR, Hinman LM, Beyer CF, Greenberger LM, Lin C, Lindh D, Menendez AT, Wallace R, Durr FE, Upeslacis J. Hamann PR, et al. Bioconjug Chem. 2005 Mar-Apr;16(2):346-53. doi: 10.1021/bc049795f. Bioconjug Chem. 2005. PMID: 15769088
Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
Harper J, Mao S, Strout P, Kamal A. Harper J, et al. Methods Mol Biol. 2013;1045:41-9. doi: 10.1007/978-1-62703-541-5_3. Methods Mol Biol. 2013. PMID: 23913140
Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates.
Erickson HK, Widdison WC, Mayo MF, Whiteman K, Audette C, Wilhelm SD, Singh R. Erickson HK, et al. Bioconjug Chem. 2010 Jan;21(1):84-92. doi: 10.1021/bc900315y. Bioconjug Chem. 2010. PMID: 19891424
Antibody-targeted drugs for the therapy of cancer.
Pietersz GA, Krauer K. Pietersz GA, et al. J Drug Target. 1994;2(3):183-215. doi: 10.3109/10611869408996804. J Drug Target. 1994. PMID: 7812691 Review.

See all similar articles

Cited by

Construction of homogeneous antibody-drug conjugates using site-selective protein chemistry.
Akkapeddi P, Azizi SA, Freedy AM, Cal PMSD, Gois PMP, Bernardes GJL. Akkapeddi P, et al. Chem Sci. 2016 May 1;7(5):2954-2963. doi: 10.1039/c6sc00170j. Epub 2016 Feb 12. Chem Sci. 2016. PMID: 29997785 Free PMC article. Review.
Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
Staudacher AH, Brown MP. Staudacher AH, et al. Br J Cancer. 2017 Dec 5;117(12):1736-1742. doi: 10.1038/bjc.2017.367. Epub 2017 Oct 24. Br J Cancer. 2017. PMID: 29065110 Free PMC article. Review.
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
Senter PD, Sievers EL. Senter PD, et al. Nat Biotechnol. 2012 Jul 10;30(7):631-7. doi: 10.1038/nbt.2289. Nat Biotechnol. 2012. PMID: 22781692
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates.
Kang MS, Kong TWS, Khoo JYX, Loh TP. Kang MS, et al. Chem Sci. 2021 Oct 6;12(41):13613-13647. doi: 10.1039/d1sc02973h. eCollection 2021 Oct 27. Chem Sci. 2021. PMID: 34760149 Free PMC article. Review.
Unnatural amino acid incorporation in E. coli: current and future applications in the design of therapeutic proteins.
Wals K, Ovaa H. Wals K, et al. Front Chem. 2014 Apr 1;2:15. doi: 10.3389/fchem.2014.00015. eCollection 2014. Front Chem. 2014. PMID: 24790983 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information